Compare MREO & WSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MREO | WSHP |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United Kingdom | British Virgin Islands |
| Employees | N/A | 20 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 60.8M |
| IPO Year | 2017 | N/A |
| Metric | MREO | WSHP |
|---|---|---|
| Price | $0.34 | $5.68 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 623.4K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $5,184.20 | N/A |
| Revenue Next Year | $55.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $4.62 |
| 52 Week High | $2.37 | $250.00 |
| Indicator | MREO | WSHP |
|---|---|---|
| Relative Strength Index (RSI) | 57.32 | 44.38 |
| Support Level | $0.29 | $4.91 |
| Resistance Level | $0.36 | $7.88 |
| Average True Range (ATR) | 0.03 | 1.35 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 88.36 | 17.82 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.